The eighth annual Dance Party to End ALZ has raised over $300,000 and counting for the Alzheimer’s Association’s research grant program. The fundraising event combined live performances and entertainment with an effort to accelerate research for millions of people affected by dementia.
Fundraising event targets Alzheimer’s research
The event took place Sunday as a pajama-themed party, with proceeds supporting the Alzheimer’s Association’s research grant program.
Sunday’s 8th Annual Dance Party to End ALZ may have been a pajama party, but not a single attendee slept through the fun as they raised $300,000 (and counting) to support the Alzheimer’s Association’s research grant program!
Dance Party to End ALZ is an evening dedicated to… pic.twitter.com/inrNIsGszx
— Alzheimer’s Association (@alzassociation) September 16, 2026
Organizers described Dance Party to End ALZ as an evening focused on advancing scientific breakthroughs and research for Alzheimer’s disease and other forms of dementia.
At press time, the Alzheimer’s Association disclosed that the fundraising event has garnered over $300,000 and counting. The latest fundraising total brings the event’s cumulative contribution to more than $2 million, according to organizers.
The event featured television personalities and performers who helped bring the fundraiser to the stage.
Nikki DeLoach and Ashley Williams served as hosts, while Melissa Peterman and Jonathan Bennett served as emcees. Performers also took the stage to perform songs as attendees supported the fundraising effort.
Dance Party to End ALZ directs its fundraising toward the Alzheimer’s Association’s research grant program, which supports scientific work focused on understanding and addressing Alzheimer’s disease and related dementias.
Alzheimer’s Association advocacy pushes bipartisan screening bill forward
The Dance Party to End ALZ fundraiser comes as the Alzheimer’s Association is pushing the bipartisan Alzheimer’s Screening and Prevention Act (ASAP) forward. The effort gained momentum on September 15 when the House Ways and Means Committee unanimously advanced the bill, teeing it up for a potential floor vote.
Earlier today, the bipartisan Alzheimer's Screening and Prevention (ASAP) Act took an important step forward into becoming law. Every member of the House Ways & Means Committee voted in favor of sending the bill to the floor of Representatives.
We want to thank every #ENDALZ… pic.twitter.com/cPPLFneIhq
— Alzheimer's Association (@alzassociation) September 16, 2026
The bill seeks to create a pathway for Medicare to cover FDA-approved or cleared blood-based tests for detecting Alzheimer’s disease and related dementias at an earlier stage.
Under current Medicare rules, coverage cannot extend to dementia screening for people who do not have symptoms. The Alzheimer’s Association argues that the legislation would remove that barrier and give Medicare a pathway to cover emerging blood-based screening tools through an evidence-based process.